From 3rd to 6th of November, PlumStars will participate at AAPS 2019 AAPS, an annual Conference of the American Association of Pharmaceutical Scientists that will be held at Henry B. González Convention Center, San Antonio, TX, USA.

There will be pitching, demonstrations and great presentations, with take-aways for both investors and innovation driven organizations.

Prof. Paolo Colombo (PlumeStars CEO) will present two different speeches:

  • “Hyaluronic-Cisplatin Film for Implant for Malignant Mesothelioma Recurrences”.
  • “Flurbiprofen powders for nose-to-brain delivery as alzheimer’s disease modifying agent”.

The first speech concerns Hyalcis exploits nanotechnology and advanced material research results to bring to market an innovative medical treatment of mesothelioma. The studies until now conducted revealed an interaction between the polymer hyaluronic acid and cisplatin that gave rise to a drug-polymer complex, lymphatically absorbed and blood distributed.

The uptake by pharmaceutical industry of the hyaluronic- cisplatin film technology studied by PlumeStars will assign a more effective cure against recurrences of this rare and very aggressive form of cancer that is difficult to diagnose and highly resistant to anticancer drugs.

Dr. Eride Quarta (PharmD; PhD Student, PlumeStars Research Leader) will present:

  • “Novel Insulin Powder: bioavalability in rats”.

AAPS PharmSci 360 combines all the energy of a large scientific conference with the intimacy of a niche meeting.

Five robust tracks covering all aspects of the pharmaceutical sciences, hundreds of exhibitors with dozens of additional learning opportunities, thousands of scientific posters featuring the latest, most innovative research in the field.

Co-funded by the European Union

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Unisciti a 3 altri iscritti